Considering we detected no recurrent non-V600E BRAF, KIT, or NF1 mutations in naevi, this may imply that acral melanomas harboring these mutations arise primarily de novo, whereas BRAF V600E or NRAS Q61 mutant acral melanomas may more frequently arise from pre-existing naevi. The gene discussed is NF1; the disease is acral lentiginous melanoma.